Q: 1. OTC has a design lockdown and is scheduled to begin animal trials this year.
2. It has also paid out 2 senior executives with Shares.

In your experience do you think a company letting executives go when it appears to be making progress on its research is an indicator it might be tendering a buyout? or do you think this is a sign the company is experiencing hardship and the research is not panning out?